Rathbones Group PLC Has $206.75 Million Position in Intuitive Surgical, Inc. $ISRG

Rathbones Group PLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 462,292 shares of the medical equipment provider’s stock after purchasing an additional 1,928 shares during the period. Rathbones Group PLC owned about 0.13% of Intuitive Surgical worth $206,751,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Tobam lifted its stake in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the last quarter. Kilter Group LLC bought a new position in Intuitive Surgical in the second quarter valued at about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $27,000. Caitlin John LLC acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $30,000. Finally, Guerra Advisors Inc bought a new stake in shares of Intuitive Surgical during the third quarter worth about $37,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Sanford C. Bernstein raised their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Raymond James Financial raised their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Royal Bank Of Canada lifted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $490.16 on Friday. The firm has a market cap of $174.07 billion, a PE ratio of 62.12, a price-to-earnings-growth ratio of 3.78 and a beta of 1.66. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The business’s 50 day moving average price is $521.64 and its two-hundred day moving average price is $512.28.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.21 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the sale, the director directly owned 3,694 shares in the company, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 37,261 shares of company stock valued at $19,690,721 in the last ninety days. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.